CE Education
The Treatment of R/R cHL in the Era of Checkpoint Inhibitors
Catherine Diefenbach, MD |
Continuing Education for Nurses
Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse
Amy L. Goodrich, RN, MSN, CRNP; Mollie E. Moran, MSN, CNP, AOCNP |
CE Education
Advanced-stage cHL: Rethinking Our Options in Frontline Therapy
Jonathon B. Cohen, MD, MS |
CE Education
Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma
Alison J. Moskowitz, MD |
CE Education
Immunotherapy in Hodgkin Lymphoma: Current and Future Approaches to Treatment
Anas Younes, MD |
FAQ Library
How do you evaluate patients' response to immunotherapy?
Matthew Matasar, MD |
FAQ Library
What are the potential immune-related toxicities to be mindful of when prescribing nivo and pembro?
Anas Younes, MD |
Clinical Case Snapshots
32-year-old male who had progression in his spine and received radiation therapy
Jonathon B. Cohen, MD, MS |
Clinical Case Snapshots
22-year-old female who presented with lower extremity swelling and abdominal pain
Jonathon B. Cohen, MD, MS |
